CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 35 enrolled
Drug / intervention
2-MHz transcranial Doppler ultrasound +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01240356
NCT01240356Phase 2Completed

Combined Lysis of Thrombus in Brain Ischemia With Transcranial Ultrasound and Systemic T-PA-Hands-Free. A Phase I/II Pilot Safety Trial

The University of Texas Health Science Center, Houston·interventional·Posted Nov 15, 2010·Updated May 23, 2016

In Brief

A Phase 2 clinical trial evaluating 2-MHz transcranial Doppler ultrasound and 2-MHz transcranial Doppler ultrasound insonation for Stroke. Completed, enrolled 35 participants across 2 sites.

Detailed Summary

The purpose of CLOTBUST-HF is to determine the safety of a novel, external Hands-Free transcranial Doppler (TCD) ultrasound system in healthy volunteers and ischemic stroke patients. If found to be safe, the widespread use of operator-independent, ultrasound-enhanced thrombolysis will allow the planning for a large Phase III efficacy trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesUnited States

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 15, 2010
Enrollment StartDec 1, 2008
Primary CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 15.6 years ago

Interventions

2-MHz transcranial Doppler ultrasounddevice

2-hours of hands-free ultrasound will be insonated continuously. A brain MRI with gadolinium will be performed before and after the ultrasound.

2-MHz transcranial Doppler ultrasound insonationdevice

2-hours of hands-free ultrasound delivered to in the intracranial vessels.